A dual mRNA-LNP vaccine encoding Leishmania PEPCK and IL-12 to promote durable dermal-resident memory T cell responses.
Researchers developed an LNP-mRNA-based vaccine that encodes different cytokine mRNAs, as a method to enhance CD8+ T cell responses and memory formation.